REAGILA

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, South Africa, Spain, Turkey, UK.

Active ingredients

The drug REAGILA contains one active pharmaceutical ingredient (API):

1	Cariprazine UNII KQD7C255YG - CARIPRAZINE HYDROCHLORIDE
	Cariprazine is indicated for the treatment of schizophrenia in adult patients. The mechanism of action of cariprazine is not fully known. However the therapeutic effect of cariprazine may be mediated through a combination of partial agonist activity at dopamine D3, D2 (Ki values of 0.085-0.3 nM versus 0.49-0.71 nM respectively) and serotonin 5-HT1A receptors (Ki values of 1.4-2.6 nM), and antagonist activity at serotonin 5-HT2B, 5-HT2A and histamine H1 receptors (Ki values of 0.58-1.1 nM, 18.8 nM and 23.3 nM, respectively).
	Read more about Cariprazine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
REAGILA Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AX15		N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1749809, 1749810, 1749821, 1749832, 1749843, 1749854, 1749865, 1749876, 1749887, 1749898, 1749900, 1749911, 1749922, 1749933, 1749944, 1749955, 1749966, 1749977, 1749988, 1749999, 1750025, 1750036, 1750047, 1750058, 1750069, 1750070, 1750081, 1750092, 1750104, 1750115, 1750126, 1750137, 1750148, 1750159, 1750160, 1750171, 1786899, 1786901, 1786912, 1786923
ES	Centro de información online de medicamentos de la AEMPS	1171209001, 1171209011, 1171209021, 1171209029
FI	Lääkealan turvallisuus- ja kehittämiskeskus	132370, 168071, 482466, 517228
GB	Medicines & Healthcare Products Regulatory Agency	357719, 357722, 357725, 357728
IE	Health Products Regulatory Authority	36010, 36012, 36013, 36014
IL	מִשְׂרַד הַבְּרִיאוּת	8588, 8589, 8590, 8591
IT	Agenzia del Farmaco	045490012, 045490024, 045490036, 045490048, 045490051, 045490063, 045490075, 045490087, 045490099, 045490101, 045490113, 045490125, 045490137, 045490149, 045490152, 045490164, 045490176, 045490188, 045490190, 045490202, 045490214, 045490226, 045490238, 045490240, 045490253, 045490265, 045490277, 045490289, 045490291, 045490303, 045490315, 045490327, 045490339, 045490341, 045490354, 045490366, 045490378, 045490380, 045490392, 045490404, 045490416, 045490428
LT	Valstybinė vaistų kontrolės tarnyba	1083430, 1083431, 1083432, 1083433, 1083434, 1083435, 1083436, 1083437, 1083438, 1083439, 1083440, 1083441, 1083442, 1083443, 1083444, 1083445, 1083446, 1083447, 1083448, 1083449, 1083450, 1083451, 1083452, 1083453, 1083454, 1083455, 1083456, 1083457, 1083458, 1083459, 1083460, 1083461, 1083462, 1083463, 1083464, 1083465, 1085090, 1085091, 1085092, 1085093
NL	Z-Index G-Standaard, PRK	159123, 159131, 159158, 159166
PL	Rejestru Produktów Leczniczych	100390771, 100390788, 100390794, 100390802
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64027001, W64027002, W64027003, W64027004, W64027005, W64027006, W64027007, W64027008, W64027009, W64027010, W64028001, W64028002, W64028003, W64028004, W64028005, W64028006, W64028007, W64028008, W64028009, W64028010, W64029001, W64029002, W64029003, W64029004, W64029005, W64029006, W64029007, W64029008, W64030001, W64030002, W64030003, W64030004, W64030005, W64030006, W64030007, W64030008
TR	İlaç ve Tıbbi Cihaz Kurumu	8699559150100, 8699559150117, 8699559150124, 8699559150131, 8699559150148, 8699559150155, 8699559150162, 8699559150179
ZA	Health Products Regulatory Authority	55/2.6.5/0097, 55/2.6.5/0098, 55/2.6.5/0099, 55/2.6.5/0100